Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.
Michael M B GreenNelson ChaoSaurabh ChhabraKelly CorbetCristina GasparettoAri HorwitzZhiguo LiJagadish Kummetha VenkataGwynn LongAlice MimsDavid RizzieriStefanie SarantopoulosRobert StuartAnthony D SungKeith M SullivanLuciano CostaMitchell HorwitzYubin KangPublished in: Journal of hematology & oncology (2016)
ClinicalTrials.gov NCT01280955.